ADKUDO
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99352301
- Mark type
- Stylized text
- Filed
- 22 Aug 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Joel R. Feldman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders; all of the foregoing excluding pharmaceutical preparations or therapeutic agents administered by infusion or for treating hematological diseases, hematological disorders, or blood cancers
Owner
- Corcept Therapeutics Incorporated, Redwood City, CA, US
- Corcept Therapeutics Incorporated, Redwood City, CA, US
Prosecution history
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Oct 2025 — NON-FINAL ACTION E-MAILED
- 23 Oct 2025 — NON-FINAL ACTION WRITTEN
- 22 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Oct 2025 — NON-FINAL ACTION E-MAILED
- 22 Oct 2025 — NON-FINAL ACTION WRITTEN
- 22 Oct 2025 — ASSIGNED TO EXAMINER
- 22 Aug 2025 — APPLICATION FILING RECEIPT MAILED